Zahravi Pharmaceutical (DZAH) Lifts Six-Month Net Profit 313% to 6,386 Billion Rials From 1,546 Billion
Sahmino Newsroom | 16 November 2026 | 4 days ago
In its interim financial statements for the six months to 31 Shahrivar 1405 (22 September 2026), filed on Codal on 25 Aban 1405 (16 November 2026), Zahravi Pharmaceutical (DZAH) reported operating revenue of 17,123 billion rials, 136% above the 7,270 billion rials of the same period a year earlier (restated). Cost of sales was 7,051 billion rials, gross profit rose 222% to 10,072 billion rials, and operating profit reached 8,733 billion rials.
Net profit was 6,386 billion rials against 1,546 billion rials a year earlier, an increase of 313%. Basic earnings per share were 601 rials against 145 rials, and share capital stayed unchanged at 10,634 billion rials. The current-period column in the form is labelled "for submission to the auditor". The figures are from the company's standalone income statement.
Sahmino context
What the prices have done since this story was published, and what Sahmino wrote around it
Sahmino's reading
The gross margin rose from about 43% of revenue to about 59% (Sahmino's own calculation from the same income statement); the tax charge was 1,872 billion rials, against 437 billion rials a year earlier.
Since this story was published, DZAH rose 0.2 percent, to 6,360 rials.
Over the same days, Tehran Stock Exchange Index fell 1.4 percent, to 8,392,018.
Over the same days, US Dollar rose 0.5 percent, to 2,699,700 rials.
- DZAH
- +0.2%
- Tehran Stock Exchange Index
- −1.4%
- US Dollar
- +0.5%
Prices to the close of 19 November
From Sahmino that week
Major holder exits NIRN: Code of Exchange-Traded Funds
Calendar | 17 NovemberNew major holder in NIRN: Atiyeh Health and Safety Support Institute at 4.8%
Calendar | 17 NovemberNasir Machine's own estimate for its doubled Megamotor crankshaft price: more gross profit, but not double (Monday 16 November 2026)
Article | 16 NovemberWarren Buffett's simple rules: five lines from his own letters, each with an example from the Tehran market
Article | 16 November
More from this market
Zagros Darou Parsian (ZGDZ) Lifts Six-Month Net Profit 358% to 35,031 Billion Rials as Revenue Rises 3.96-Fold, 2.3 Times All of Fiscal 1404
Stocks | 20 hours agoDarupakhsh Factories (DPAK) Lifts Six-Month Net Profit 7.2-Fold to 60,998 Billion Rials at a 66.1% Gross Margin
Stocks | 16 hours agoDarupakhsh Pharmaceutical Raw Materials (TMVD) Books 18,401 Billion Rials of Six-Month Net Profit, Up 248% and 148% of All of Fiscal 1404
Stocks | yesterdayDaropakhsh Distribution (DPDZ) Lifts Six-Month Net Profit 256%; Revenue Tops Last Full Year, but Gross Margin Stays Near 10%
Stocks | 3 days ago
